Insider Trading activities at Genmark Diagnostics, Inc. (GNMK)

Insider trading activities (stock purchases, sales, and option exercises) reported by insiders of Genmark Diagnostics, Inc. (GNMK) since 2014 are shown in Table 1 and Table 2. Table 1 shows the monthly insider trading data of Genmark Diagnostics, Inc.. Table 2 shows the detailed insider transactions. This company's CIK number is 1487371.

Total stock buying since 2014: $765,645.
Total stock sales since 2014: $24,976,791.
Total stock option exercises since 2014: $2,145,948.


 1   2   3   4 
23 insiders reported insider trading activities at Genmark Diagnostics, Inc. (GNMK):
Insider trading activities of Ek John Frederick
Insider trading activities of Williams Jennifer Anne
Insider trading activities of Hawkins Jeffrey Alan
Insider trading activities of Winkler Sarah Hollis
Insider trading activities of Oboyle Kevin C
Insider trading activities of Maderazo Alan Baer
Insider trading activities of Fox James
Insider trading activities of Faulkner Daryl
Insider trading activities of Gleeson Michael
Insider trading activities of Mcnally James B.
Insider trading activities of Giles Lisa M.
Insider trading activities of Mendel Scott
Insider trading activities of Harkins Michael John
Insider trading activities of Chakravarty Ingo
Insider trading activities of Slansky Richard B
Insider trading activities of Jensen Tyler
Insider trading activities of Kagnoff Michael
Insider trading activities of Mitchell Brian Andrew
Insider trading activities of Stier Eric
Insider trading activities of Kayyem Jon Faiz
Insider trading activities of Massarany Hany
Insider trading activities of Shaw Christine
Insider trading activities of O'brien Scott Alexander

Table 1. Yearly summary of insider stock purchases, sales, and option exercises at Genmark Diagnostics, Inc. (GNMK).
Insider Buying Insider Sales Option Exercises
Year Shares Value Shares Value Shares Value
2021 0 $0 385,359 $5,822,238 602,256 $707,339
2020 29,800 $144,524 696,530 $8,453,929 272,161 $1,180,309
2019 0 $0 430,188 $2,804,893 135,392 $258,300
2018 10,000 $42,200 197,291 $1,121,778 0 $0
2017 22,500 $105,475 272,420 $2,777,946 175,116 $0
2016 4,823 $56,336 113,064 $996,532 3,839 $0
2015 54,500 $417,110 193,385 $2,147,497 10,800 $0
2014 0 $0 77,068 $851,978 0 $0

Table 2. Monthly summary of insider trading at Genmark Diagnostics, Inc. (GNMK).
Trading Period Insider Buying Insider Sales Option Exercises
year-month Shares Value Shares Value Shares Value
2021-04 0 $0 0 $0 27,667 $335,324
2021-03 0 $0 3,401 $67,272 0 $0
2021-02 0 $0 53,496 $937,159 0 $0
2021-01 0 $0 328,462 $4,817,807 574,589 $372,015
2020-12 0 $0 17,016 $253,087 0 $0
2020-11 0 $0 90,330 $1,173,510 0 $0
2020-10 0 $0 73,571 $1,091,370 58,680 $724,874
2020-09 0 $0 52,974 $711,777 0 $0
2020-08 0 $0 259,871 $3,977,834 0 $0
2020-07 0 $0 6,171 $95,357 0 $0
2020-06 0 $0 4,780 $46,009 0 $0
2020-05 0 $0 34,928 $360,067 56,816 $368,735
2020-04 0 $0 15,848 $140,049 14,450 $86,700
2020-03 29,800 $144,524 2,000 $7,000 0 $0
2020-02 0 $0 78,103 $298,261 0 $0
2020-01 0 $0 60,938 $299,608 142,215 $0
2019-11 0 $0 75,938 $418,994 0 $0
2019-10 0 $0 4,926 $28,964 0 $0
2019-08 0 $0 69,309 $429,548 43,050 $258,300
2019-05 0 $0 57,420 $398,626 0 $0
2019-04 0 $0 10,000 $75,100 0 $0
2019-02 0 $0 175,858 $1,236,915 0 $0
2019-01 0 $0 36,737 $216,746 92,342 $0
2018-11 0 $0 28,295 $139,333 0 $0

Table 3. Detailed insider trading at Genmark Diagnostics, Inc. (GNMK)
  Trade Date   Insider Name Trade Type     Shares       Price ($)   Value ($)
2021-04-14 Gleeson Michael (SVP, Corp. Accounts) Option Ex 27,667 12.12 335,324
2021-03-18 Jensen Tyler (SVP, Engineering and Tech Dev) Sale 500 23.88 11,940
2021-03-05 Shaw Christine (VP, Assay Development) Sale 274 18.56 5,085
2021-03-04 Jensen Tyler (SVP, Engineering and Tech Dev) Sale 500 18.86 9,430
2021-03-01 Maderazo Alan Baer (VP, Qual, Reg, & Clin Affairs) Sale 2,127 19.19 40,817
2021-02-26 Shaw Christine (VP, Assay Development) Sale 3,151 17.03 53,661
2021-02-26 Harkins Michael John (SVP, Sales) Sale 12,381 17.03 210,848
2021-02-26 Winkler Sarah Hollis (VP, Human Resources) Sale 11,181 17.01 190,188
2021-02-26 Gleeson Michael (SVP, Corp. Accounts) Sale 17,750 17.01 301,927
2021-02-25 Maderazo Alan Baer (VP, Qual, Reg, & Clin Affairs) Sale 266 19.16 5,096
2021-02-24 Shaw Christine (VP, Assay Development) Sale 259 19.12 4,952
2021-02-24 Maderazo Alan Baer (VP, Qual, Reg, & Clin Affairs) Sale 163 19.12 3,116
2021-02-24 Gleeson Michael (SVP, Corp. Accounts) Sale 2,463 19.12 47,092
2021-02-23 Shaw Christine (VP, Assay Development) Sale 166 19.35 3,212
2021-02-23 Gleeson Michael (SVP, Corp. Accounts) Sale 1,432 19.35 27,709
2021-02-22 Maderazo Alan Baer (VP, Qual, Reg, & Clin Affairs) Sale 290 20.36 5,904
2021-02-19 Winkler Sarah Hollis (VP, Human Resources) Sale 654 21.80 14,257
2021-02-19 Gleeson Michael (SVP, Corp. Accounts) Sale 2,340 21.80 51,012
2021-02-18 Jensen Tyler (SVP, Engineering and Tech Dev) Sale 500 21.68 10,840
2021-02-04 Jensen Tyler (SVP, Engineering and Tech Dev) Sale 500 14.69 7,345
2021-01-27 Shaw Christine (VP, Assay Development) Sale 81 14.06 1,138
2021-01-27 O'brien Scott Alexander (SVP, Global Mktg & Int'l Sales) Sale 180 14.06 2,530
2021-01-27 Harkins Michael John (SVP, Sales) Sale 1,117 14.06 15,705
2021-01-27 Winkler Sarah Hollis (VP, Human Resources) Sale 783 14.06 11,008
2021-01-27 Jensen Tyler (SVP, Engineering and Tech Dev) Sale 322 14.06 4,527
2021-01-26 Maderazo Alan Baer (VP, Qual, Reg, & Clin Affairs) Sale 6,214 15.19 94,390
2021-01-25 Maderazo Alan Baer (VP, Qual, Reg, & Clin Affairs) Sale 23,764 14.22 337,924
2021-01-25 O'brien Scott Alexander (SVP, Global Mktg & Int'l Sales) Sale 6,458 14.23 91,897
2021-01-25 Harkins Michael John (SVP, Sales) Sale 7,338 14.22 104,346
2021-01-25 Winkler Sarah Hollis (VP, Human Resources) Sale 10,317 14.22 146,707
2021-01-25 Jensen Tyler (SVP, Engineering and Tech Dev) Sale 20,953 14.23 298,161
2021-01-25 Ek John Frederick (Chief Financial Officer) Sale 18,475 14.24 263,084
2021-01-25 Stier Eric (SVP & General Counsel) Sale 29,658 14.22 421,736
2021-01-25 Gleeson Michael (SVP, Corp. Accounts) Sale 33,027 14.22 469,643
2021-01-25 Mendel Scott (President & CEO) Sale 64,975 14.23 924,594
2021-01-21 Maderazo Alan Baer (VP, Qual, Reg, & Clin Affairs) Option Ex 65,185 .00 0
2021-01-21 O'brien Scott Alexander (SVP, Global Mktg & Int'l Sales) Option Ex 16,666 .00 0
2021-01-21 Harkins Michael John (SVP, Sales) Option Ex 19,166 .00 0
2021-01-21 Winkler Sarah Hollis (VP, Human Resources) Option Ex 27,511 .00 0
2021-01-21 Jensen Tyler (SVP, Engineering and Tech Dev) Sale 500 14.93 7,465
2021-01-21 Jensen Tyler (SVP, Engineering and Tech Dev) Option Ex 56,864 .00 0
2021-01-21 Ek John Frederick (Chief Financial Officer) Option Ex 50,449 .00 0
2021-01-21 Stier Eric (SVP & General Counsel) Option Ex 77,240 .00 0
2021-01-21 Gleeson Michael (SVP, Corp. Accounts) Option Ex 83,836 .00 0
2021-01-21 Mendel Scott (President & CEO) Option Ex 146,172 .00 0
2021-01-20 Maderazo Alan Baer (VP, Qual, Reg, & Clin Affairs) Sale 5,000 15.00 75,000
2021-01-19 Mendel Scott (President & CEO) Sale 50,000 14.54 727,000
2021-01-07 Jensen Tyler (SVP, Engineering and Tech Dev) Sale 32,477 16.99 551,784
2021-01-07 Jensen Tyler (SVP, Engineering and Tech Dev) Option Ex 31,500 11.81 372,015
2021-01-06 Jensen Tyler (SVP, Engineering and Tech Dev) Sale 16,823 16.00 269,168
2020-12-24 Jensen Tyler (SVP, Engineering and Tech Dev) Sale 500 15.00 7,500
2020-12-21 Maderazo Alan Baer (VP, Qual, Reg, & Clin Affairs) Sale 15,000 15.00 225,000
2020-12-10 Jensen Tyler (SVP, Engineering and Tech Dev) Sale 500 12.79 6,395
2020-12-07 Shaw Christine (VP, Assay Development) Sale 274 13.97 3,827
2020-12-07 O'brien Scott Alexander (SVP, Global Mktg & Int'l Sales) Sale 742 13.97 10,365
2020-11-27 Jensen Tyler (SVP, Engineering and Tech Dev) Sale 500 12.42 6,210
2020-11-25 Maderazo Alan Baer (VP, Qual, Reg, & Clin Affairs) Sale 552 12.72 7,021
2020-11-24 Shaw Christine (VP, Assay Development) Sale 355 13.17 4,675
2020-11-24 Maderazo Alan Baer (VP, Qual, Reg, & Clin Affairs) Sale 1,994 13.17 26,260
2020-11-24 O'brien Scott Alexander (SVP, Global Mktg & Int'l Sales) Sale 1,144 13.17 15,066
2020-11-24 Jensen Tyler (SVP, Engineering and Tech Dev) Sale 1,132 13.17 14,908
2020-11-24 Ek John Frederick (Chief Financial Officer) Sale 1,418 13.17 18,675
2020-11-24 Stier Eric (SVP & General Counsel) Sale 2,512 13.17 33,083
2020-11-24 Gleeson Michael (SVP, Corp. Accounts) Sale 3,234 13.17 42,591
2020-11-24 Mendel Scott (President & CEO) Sale 5,190 13.17 68,352
2020-11-20 Maderazo Alan Baer (VP, Qual, Reg, & Clin Affairs) Sale 366 13.01 4,761
2020-11-19 Maderazo Alan Baer (VP, Qual, Reg, & Clin Affairs) Sale 1,310 13.85 18,143
2020-11-19 Winkler Sarah Hollis (VP, Human Resources) Sale 656 13.85 9,085
2020-11-19 Jensen Tyler (SVP, Engineering and Tech Dev) Sale 1,146 13.85 15,872
2020-11-19 Ek John Frederick (Chief Financial Officer) Sale 1,637 13.85 22,672
2020-11-19 Stier Eric (SVP & General Counsel) Sale 1,555 13.85 21,536
2020-11-19 Gleeson Michael (SVP, Corp. Accounts) Sale 1,637 13.85 22,672
2020-11-19 Mendel Scott (President & CEO) Sale 3,987 13.85 55,219
2020-11-12 Jensen Tyler (SVP, Engineering and Tech Dev) Sale 500 13.68 6,840
2020-11-11 Stier Eric (SVP & General Counsel) Sale 59,293 12.77 757,171
2020-11-03 O'brien Scott Alexander (SVP, Global Mktg & Int'l Sales) Sale 212 12.73 2,698
2020-10-29 Jensen Tyler (SVP, Engineering and Tech Dev) Sale 500 11.32 5,660
2020-10-27 Shaw Christine (VP, Assay Development) Sale 68 11.34 771
2020-10-27 O'brien Scott Alexander (SVP, Global Mktg & Int'l Sales) Sale 177 11.34 2,007
2020-10-27 Harkins Michael John (SVP, Sales) Sale 1,092 11.34 12,383
2020-10-27 Winkler Sarah Hollis (VP, Human Resources) Sale 765 11.34 8,675
2020-10-27 Jensen Tyler (SVP, Engineering and Tech Dev) Sale 220 11.34 2,494
2020-10-15 Jensen Tyler (SVP, Engineering and Tech Dev) Sale 500 11.83 5,915
2020-10-07 Maderazo Alan Baer (VP, Qual, Reg, & Clin Affairs) Sale 69,749 15.00 1,046,235
2020-10-07 Maderazo Alan Baer (VP, Qual, Reg, & Clin Affairs) Option Ex 58,680 12.35 724,874
2020-10-01 Jensen Tyler (SVP, Engineering and Tech Dev) Sale 500 14.46 7,230
2020-09-22 Ek John Frederick (Chief Financial Officer) Sale 41,196 13.82 569,328
2020-09-17 Jensen Tyler (SVP, Engineering and Tech Dev) Sale 500 12.72 6,360
2020-09-16 Ek John Frederick (Chief Financial Officer) Sale 5,723 12.98 74,284
2020-09-08 Shaw Christine (VP, Assay Development) Sale 285 11.02 3,140
2020-09-08 O'brien Scott Alexander (SVP, Global Mktg & Int'l Sales) Sale 770 11.02 8,485
2020-09-08 Mitchell Brian Andrew (SVP, Operations) Sale 4,000 11.02 44,080
2020-09-03 Jensen Tyler (SVP, Engineering and Tech Dev) Sale 500 12.20 6,100
2020-08-27 Maderazo Alan Baer (VP, Qual, Reg, & Clin Affairs) Sale 891 13.10 11,672
2020-08-26 Mitchell Brian Andrew (SVP, Operations) Sale 3,464 14.74 51,059
2020-08-26 Mendel Scott (President & CEO) Sale 50,000 15.02 751,000
2020-08-25 Shaw Christine (VP, Assay Development) Sale 379 14.14 5,359
2020-08-25 Maderazo Alan Baer (VP, Qual, Reg, & Clin Affairs) Sale 2,130 14.14 30,118
2020-08-25 O'brien Scott Alexander (SVP, Global Mktg & Int'l Sales) Sale 1,223 14.14 17,293
2020-08-25 Jensen Tyler (SVP, Engineering and Tech Dev) Sale 1,211 14.14 17,123
2020-08-25 Ek John Frederick (Chief Financial Officer) Sale 1,515 14.14 21,422
2020-08-25 Mitchell Brian Andrew (SVP, Operations) Sale 2,083 14.14 29,453
2020-08-25 Stier Eric (SVP & General Counsel) Sale 2,684 14.14 37,951
2020-08-25 Gleeson Michael (SVP, Corp. Accounts) Sale 2,904 14.14 41,062
2020-08-25 Mendel Scott (President & CEO) Sale 4,532 14.14 64,082
2020-08-21 Mitchell Brian Andrew (SVP, Operations) Sale 2,997 15.62 46,813
2020-08-20 Maderazo Alan Baer (VP, Qual, Reg, & Clin Affairs) Sale 1,353 15.41 20,849
2020-08-20 Winkler Sarah Hollis (VP, Human Resources) Sale 677 15.41 10,432
2020-08-20 Jensen Tyler (SVP, Engineering and Tech Dev) Sale 1,184 15.41 18,245
2020-08-20 Ek John Frederick (Chief Financial Officer) Sale 2,591 15.69 40,652
2020-08-20 Mitchell Brian Andrew (SVP, Operations) Sale 1,691 15.41 26,058
2020-08-20 Stier Eric (SVP & General Counsel) Sale 1,606 15.41 24,748
2020-08-20 Gleeson Michael (SVP, Corp. Accounts) Sale 1,691 15.41 26,058
2020-08-20 Mendel Scott (President & CEO) Sale 2,988 15.41 46,045
2020-08-19 Mitchell Brian Andrew (SVP, Operations) Sale 44,881 15.52 696,553
2020-08-18 Ek John Frederick (Chief Financial Officer) Sale 28,307 15.98 452,345
2020-08-18 Mitchell Brian Andrew (SVP, Operations) Sale 420 15.85 6,657
2020-08-17 O'brien Scott Alexander (SVP, Global Mktg & Int'l Sales) Sale 36,570 15.38 562,446
2020-08-14 Ek John Frederick (Chief Financial Officer) Sale 5,070 15.97 80,967
2020-08-12 Mendel Scott (President & CEO) Sale 50,000 15.08 754,000
2020-08-04 O'brien Scott Alexander (SVP, Global Mktg & Int'l Sales) Sale 208 18.93 3,937
2020-08-04 Mitchell Brian Andrew (SVP, Operations) Sale 621 18.93 11,755
2020-08-03 Mitchell Brian Andrew (SVP, Operations) Sale 4,000 17.92 71,680
2020-07-28 O'brien Scott Alexander (SVP, Global Mktg & Int'l Sales) Sale 170 17.30 2,941
2020-07-28 Harkins Michael John (SVP, Sales) Sale 1,052 17.30 18,199
2020-07-28 Winkler Sarah Hollis (VP, Human Resources) Sale 737 17.30 12,750
2020-07-28 Jensen Tyler (SVP, Engineering and Tech Dev) Sale 212 17.30 3,667
2020-07-01 Mitchell Brian Andrew (SVP, Operations) Sale 4,000 14.45 57,800
2020-06-08 O'brien Scott Alexander (SVP, Global Mktg & Int'l Sales) Sale 780 9.14 7,129
2020-06-01 Mitchell Brian Andrew (SVP, Operations) Sale 4,000 9.72 38,880
2020-05-28 Maderazo Alan Baer (VP, Qual, Reg, & Clin Affairs) Sale 2,066 9.52 19,668
2020-05-28 O'brien Scott Alexander (SVP, Global Mktg & Int'l Sales) Sale 1,179 9.52 11,224
2020-05-28 Jensen Tyler (SVP, Engineering and Tech Dev) Sale 1,168 9.52 11,119
2020-05-28 Ek John Frederick (Chief Financial Officer) Sale 1,460 9.52 13,899
2020-05-28 Mitchell Brian Andrew (SVP, Operations) Sale 2,021 9.52 19,239
2020-05-28 Stier Eric (SVP & General Counsel) Sale 2,602 9.52 24,771
2020-05-28 Gleeson Michael (SVP, Corp. Accounts) Sale 2,815 9.52 26,798
2020-05-28 Mendel Scott (President & CEO) Sale 3,751 9.52 35,709
2020-05-19 Maderazo Alan Baer (VP, Qual, Reg, & Clin Affaiirs) Sale 1,319 10.46 13,796
2020-05-19 Winkler Sarah Hollis (VP, Human Resources) Sale 661 10.46 6,914
2020-05-19 Jensen Tyler (SVP, Engineering and Tech Dev) Sale 1,154 10.46 12,070
2020-05-19 Ek John Frederick (Chief Financial Officer) Sale 1,648 10.46 17,238
2020-05-19 Mitchell Brian Andrew (SVP, Operations) Sale 2,131 10.46 22,290
2020-05-19 Stier Eric (SVP & General Counsel) Sale 1,566 10.46 16,380
2020-05-19 Gleeson Michael (SVP, Corp. Accounts) Sale 1,648 10.46 17,238
2020-05-19 Mendel Scott (President & CEO) Sale 2,800 10.46 29,288
2020-05-07 Gleeson Michael (SVP, Corp. Accounts) Option Ex 56,816 6.49 368,735
2020-05-05 O'brien Scott Alexander (SVP, Global Mktg & Int'l Sales) Sale 236 13.49 3,183
2020-05-05 Mitchell Brian Andrew (SVP, Operations) Sale 703 13.49 9,483
2020-05-01 Mitchell Brian Andrew (SVP, Operations) Sale 4,000 12.44 49,760
 1   2   3   4 

Insider trading activities including stock purchases, stock sales, and option exercises of GNMK listed in the above tables cannot be completely guaranteed as to their accuracy. For more insider trading information of Genmark Diagnostics, Inc. (symbol GNMK, CIK number 1487371) see the Securities and Exchange Commission (SEC) website.



©2023, insider-monitor.com. All rights reserved.